Investments
253Portfolio Exits
58Funds
12Partners & Customers
1About Avalon Ventures
Avalon Ventures is a San Diego-based venture capital fund focusing on seed and early stage companies in life sciences, wireless communications and Web 3.0 digital media, primarily in California and the Northeast.
Avalon Ventures Headquarter Location
1134 Kline Street
La Jolla, California, 92037,
United States
858-348-2180
Expert Collections containing Avalon Ventures
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Avalon Ventures in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Avalon Ventures News
Sep 6, 2021
Joy's explosive organic growth and modern take on wedding planning enabled the company to raise USD 20 million in new funding, bringing the company's total funding to USD 46.5 million. The round was led by Valor Siren Ventures, and joined by Ashton Kutcher and Guy Oseary's Sound Ventures, Zola Global, Avalon Ventures, and Sierra Ventures.
Avalon Ventures Investments
253 Investments
Avalon Ventures has made 253 investments. Their latest investment was in Nerio Therapeutics as part of their Series A on October 10, 2021.
Avalon Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/7/2021 | Series A | Nerio Therapeutics | $3.5M | No | 1 | |
8/18/2021 | Series B | Jnana Therapeutics | $50M | No | 4 | |
7/21/2021 | Series B | Joy | $20M | No | 5 | |
4/20/2021 | Series B | |||||
3/29/2021 | Series A - II |
Date | 10/7/2021 | 8/18/2021 | 7/21/2021 | 4/20/2021 | 3/29/2021 |
|---|---|---|---|---|---|
Round | Series A | Series B | Series B | Series B | Series A - II |
Company | Nerio Therapeutics | Jnana Therapeutics | Joy | ||
Amount | $3.5M | $50M | $20M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 4 | 5 |
Avalon Ventures Portfolio Exits
58 Portfolio Exits
Avalon Ventures has 58 portfolio exits. Their latest portfolio exit was Kaltura on July 21, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/21/2021 | IPO | 8 | |||
6/11/2021 | IPO | 1 | |||
2/26/2021 | Acquired | 10 | |||
Avalon Ventures Fund History
12 Fund Histories
Avalon Ventures has 12 funds, including Avalon Ventures XI.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/6/2016 | Avalon Ventures XI | Early-Stage Venture Capital | $116.53M | 3 | |
8/30/2012 | Avalon Ventures X | Early-Stage Venture Capital | $201.63M | 1 | |
8/1/2012 | 10Th Capital Fund | $201.6M | |||
7/19/2010 | Avalon Ventures IX | ||||
2/27/2008 | Avalon Ventures VIII |
Closing Date | 9/6/2016 | 8/30/2012 | 8/1/2012 | 7/19/2010 | 2/27/2008 |
|---|---|---|---|---|---|
Fund | Avalon Ventures XI | Avalon Ventures X | 10Th Capital Fund | Avalon Ventures IX | Avalon Ventures VIII |
Fund Type | Early-Stage Venture Capital | Early-Stage Venture Capital | |||
Status | |||||
Amount | $116.53M | $201.63M | $201.6M | ||
Sources | 3 | 1 |
Avalon Ventures Partners & Customers
1 Partners and customers
Avalon Ventures has 1 strategic partners and customers. Avalon Ventures recently partnered with GlaxoSmithKline on April 4, 2013.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
4/23/2013 | Partner | GlaxoSmithKline | United Kingdom | Avalon Ventures GlaxoSmithKline Launch Sitari Pharm With 10 Million Series A And RD Support Community of Innovation , founded in 2013 , provides operational support to Sitari Pharmaceuticals , the first company funded through the Avalon-GlaxoSmithKline collaboration , as well as existing Avalon Ventures portfolio companies , Afraxis , Avelas Biosciences , RQx Pharmaceuticals and Sova Pharmaceuticals . | 4 |
Date | 4/23/2013 |
|---|---|
Type | Partner |
Business Partner | GlaxoSmithKline |
Country | United Kingdom |
News Snippet | Avalon Ventures GlaxoSmithKline Launch Sitari Pharm With 10 Million Series A And RD Support Community of Innovation , founded in 2013 , provides operational support to Sitari Pharmaceuticals , the first company funded through the Avalon-GlaxoSmithKline collaboration , as well as existing Avalon Ventures portfolio companies , Afraxis , Avelas Biosciences , RQx Pharmaceuticals and Sova Pharmaceuticals . |
Sources | 4 |
Avalon Ventures Team
8 Team Members
Avalon Ventures has 8 team members, including current Chief Financial Officer, Douglas Downs.
Name | Work History | Title | Status |
|---|---|---|---|
Douglas Downs | Chief Financial Officer | Current | |
Tighe M Reardon | Chief Financial Officer | Current | |
Kevin Kinsella | Managing Partner | Current | |
Brady Bohrmann | Managing Director | Current | |
Jay B Lichter | Managing Director | Current |